Journal of Clinical Endocrinology & Metabolism, Vol 81, 37-43, Copyright © 1996 by Endocrine Society

ARTICLES

Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women

LG Raisz, B Wiita, A Artis, A Bowen, S Schwartz, M Trahiotis, K Shoukri and J Smith
University of Connecticut Health Center, Farmington 06030, USA.

The present study was undertaken to determine whether the addition of an androgen to estrogen therapy in postmenopausal women would alter the skeletal response as determined by measurements of markers of bone formation and resorption. Postmenopausal women were treated for 9 weeks with either a combination of 1.25 mg esterified estrogen and 2.5 mg methyltestosterone (E+A) or 1.25 mg conjugated equine estrogen (CEE). Both groups showed a similar decrease in urinary excretion of the bone resorption markers, deoxypyridinoline, pyridinoline, and hydroxyproline. Patients treated with CEE showed decreases in the serum markers of bone formation, bone-specific alkaline phosphatase, osteocalcin, and C-terminal procollagen peptide. In contrast, subjects treated with E+A showed increases in these markers of bone formation. CEE increased, and E+A decreased serum levels of sex hormone-binding globulin as well as triglycerides and high density lipoprotein levels. Only CEE significantly reduced low density lipoproteins. Both regimens were effective in reducing postmenopausal somatic symptoms, but only E+A had a significant effect on psychological symptoms. We conclude that short term administration of androgen with estrogen may reverse the inhibitory effects of estrogen on bone formation. Long term studies are needed to determine the relative benefits and risks of the combination of estrogen and androgen and whether this results in greater increases in bone mass and strength.

This article has been cited by other articles:

				E. P. Smith, B. Specker, B. E. Bachrach, K. S. Kimbro, X. J. Li, M. F. Young, N. S. Fedarko, M. J. Abuzzahab, G. R. Frank, R. M. Cohen, et al. Impact on Bone of an Estrogen Receptor-{alpha} Gene Loss of Function Mutation J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3088 - 3096. [Abstract] [Full Text] [PDF]

				J. M. K. Cheong, B. R. Martin, G. S. Jackson, D. Elmore, G. P. McCabe, J. R. Nolan, S. Barnes, M. Peacock, and C. M. Weaver Soy Isoflavones Do Not Affect Bone Resorption in Postmenopausal Women: A Dose-Response Study Using a Novel Approach with 41Ca J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 577 - 582. [Abstract] [Full Text] [PDF]

				M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710. [Abstract] [Full Text] [PDF]

				R. M. Tamimi, S. E. Hankinson, W. Y. Chen, B. Rosner, and G. A. Colditz Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women Arch Intern Med, July 24, 2006; 166(14): 1483 - 1489. [Abstract] [Full Text] [PDF]

				K. K. Miller, B. M. K. Biller, C. Beauregard, J. G. Lipman, J. Jones, D. Schoenfeld, J. C. Sherman, B. Swearingen, J. Loeffler, and A. Klibanski Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1683 - 1690. [Abstract] [Full Text] [PDF]

				W. Arlt Androgen therapy in women Eur. J. Endocrinol., January 1, 2006; 154(1): 1 - 11. [Abstract] [Full Text] [PDF]

				L. M C. S M Leao, M. P. C Duarte, D. M. B Silva, P. R. V Bahia, C. M. Coeli, and M. L. F. de Farias Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study Eur. J. Endocrinol., January 1, 2006; 154(1): 131 - 139. [Abstract] [Full Text] [PDF]

				A. B. Singh, M. L. Lee, I. Sinha-Hikim, M. Kushnir, W. Meikle, A. Rockwood, S. Afework, and S. Bhasin Pharmacokinetics of a Testosterone Gel in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 136 - 144. [Abstract] [Full Text] [PDF]

				F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF]

				P. E. Lonning, J. Geisler, L. E. Krag, B. Erikstein, Y. Bremnes, A. I. Hagen, E. Schlichting, E. A. Lien, E. S. Ofjord, J. Paolini, et al. Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer J. Clin. Oncol., August 1, 2005; 23(22): 5126 - 5137. [Abstract] [Full Text] [PDF]

				K. K. Miller, K. A. Grieco, and A. Klibanski Testosterone Administration in Women with Anorexia Nervosa J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1428 - 1433. [Abstract] [Full Text] [PDF]

				P. E. Lonning Exemestane for Breast Cancer Prevention: A Feasible Strategy? Clin. Cancer Res., January 15, 2005; 11(2): 918s - 924s. [Abstract] [Full Text] [PDF]

				K. M. Wiren, X.-W. Zhang, A. R. Toombs, V. Kasparcova, M. A. Gentile, S.-I. Harada, and K. J. Jepsen Targeted Overexpression of Androgen Receptor in Osteoblasts: Unexpected Complex Bone Phenotype in Growing Animals Endocrinology, July 1, 2004; 145(7): 3507 - 3522. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]

				P. Taxel, P. M. Fall, P. C. Albertsen, R. D. Dowsett, M. Trahiotis, J. Zimmerman, C. Ohannessian, and L. G. Raisz The Effect of Micronized Estradiol on Bone Turnover and Calciotropic Hormones in Older Men Receiving Hormonal Suppression Therapy for Prostate Cancer J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4907 - 4913. [Abstract] [Full Text] [PDF]

				K. K. Miller, B. M. K. Biller, J. Hier, E. Arena, and A. Klibanski Androgens and Bone Density in Women with Hypopituitarism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2770 - 2776. [Abstract] [Full Text] [PDF]

				A. S. Dobs, T. Nguyen, C. Pace, and C. P. Roberts Differential Effects of Oral Estrogen versus Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1509 - 1516. [Abstract] [Full Text] [PDF]

				K. K. Miller Androgen Deficiency in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2395 - 2401. [Abstract] [Full Text] [PDF]

				P. Taxel, D. G. Kennedy, P. M. Fall, A. K. Willard, J. M. Clive, and L. G. Raisz The Effect of Aromatase Inhibition on Sex Steroids, Gonadotropins, and Markers of Bone Turnover in Older Men J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2869 - 2874. [Abstract] [Full Text] [PDF]

				W. P. Fairfield, J. S. Finkelstein, A. Klibanski, and S. K. Grinspoon Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2020 - 2026. [Abstract] [Full Text]

				P. J. Snyder Editorial: The Role of Androgens in Women J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1006 - 1007. [Full Text]

				J. H. Tobias, S. Clarke, K. Mitchell, S. Robins, H. Amer, and W. D. Fraser Analysis of the Contribution of Dydrogesterone to Bone Turnover Changes in Postmenopausal Women Commencing Hormone Replacement Therapy J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1194 - 1198. [Abstract] [Full Text]

				K. K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, and A. Klibanski Androgen Deficiency in Women with Hypopituitarism J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 561 - 567. [Abstract] [Full Text]

				R. S. Swerdloff and C. Wang Androgens, Estrogens, and Bone in Men Ann Intern Med, December 19, 2000; 133(12): 1002 - 1004. [Full Text] [PDF]

				J. V. Zborowski, J. A. Cauley, E. O. Talbott, D. S. Guzick, and S. J. Winters Bone Mineral Density, Androgens, and the Polycystic Ovary: The Complex and Controversial Issue of Androgenic Influence in Female Bone J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3496 - 3506. [Full Text]

				M. Javanbakht, A. B. Singh, N. A. Mazer, G. Beall, I. Sinha-Hikim, R. Shen, and S. Bhasin Pharmacokinetics of a Novel Testosterone Matrix Transdermal System in Healthy, Premenopausal Women and Women Infected with the Human Immunodeficiency Virus J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2395 - 2401. [Abstract] [Full Text]

				G. A. Laughlin, E. Barrett-Connor, D. Kritz-Silverstein, and D. von Mühlen Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 645 - 651. [Abstract] [Full Text]

				A. Rubinacci, R. Melzi, M. Zampino, A. Soldarini, and I. Villa Total and Free Deoxypyridinoline after Acute Osteoclast Activity Inhibition Clin. Chem., September 1, 1999; 45(9): 1510 - 1516. [Abstract] [Full Text] [PDF]

				B. C. Kress, I. A. Mizrahi, K. W. Armour, R. Marcus, R. D. Emkey, and A. C. Santora II Use of Bone Alkaline Phosphatase to Monitor Alendronate Therapy in Individual Postmenopausal Osteoporotic Women Clin. Chem., July 1, 1999; 45(7): 1009 - 1017. [Abstract] [Full Text] [PDF]

				S. Davis Androgen Replacement in Women: A Commentary J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1886 - 1891. [Abstract] [Full Text]

				R. R. Recker, K. M. Davies, R. M. Dowd, and R. P. Heaney The Effect of Low-Dose Continuous Estrogen and Progesterone Therapy with Calcium and Vitamin D on Bone in Elderly Women: A Randomized, Controlled Trial Ann Intern Med, June 1, 1999; 130(11): 897 - 904. [Abstract] [Full Text] [PDF]

				C. Massafra, C. De Felice, D. P. Agnusdei, D. Gioia, and F. Bagnoli Androgens and Osteocalcin during the Menstrual Cycle J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 971 - 974. [Abstract] [Full Text]

				K. M. Prestwood, D. L. Thompson, A. M. Kenny, M. J. Seibel, C. C. Pilbeam, and L. G. Raisz Low Dose Estrogen and Calcium Have an Additive Effect on Bone Resorption in Older Women J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 179 - 183. [Abstract] [Full Text]

				C. K. Lea, U. Sarma, and A. M. Flanagan Macrophage Colony Stimulating-Factor Transcripts Are Differentially Regulated in Rat Bone-Marrow by Gender Hormones Endocrinology, January 1, 1999; 140(1): 273 - 279. [Abstract] [Full Text]

				D. L. Broyles, R. G. Nielsen, E. M. Bussett, W. D. Lu, I. A. Mizrahi, P. A. Nunnelly, T. A. Ngo, J. Noell, R. H. Christenson, and B. C. Kress Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase Clin. Chem., October 1, 1998; 44(10): 2139 - 2147. [Abstract] [Full Text] [PDF]

				I. Sinha-Hikim, S. Arver, G. Beall, R. Shen, M. Guerrero, F. Sattler, C. Shikuma, J. C. Nelson, B.-M. Landgren, N. A. Mazer, et al. The Use of a Sensitive Equilibrium Dialysis Method for the Measurement of Free Testosterone Levels in Healthy, Cycling Women and in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1312 - 1318. [Abstract] [Full Text]

				A.-M. Heikkinen, M. Parviainen, L. Niskanen, M. Komulainen, M. T. Tuppurainen, H. Kroger, and S. Saarikoski Biochemical Bone Markers and Bone Mineral Density during Postmenopausal Hormone Replacement Therapy with and without Vitamin D3: A Prospective, Controlled, Randomized Study J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2476 - 2482. [Abstract] [Full Text] [PDF]